No matching items found
SHOWING Results
Eli Lilly's experimental drug donanemab slowed the progression of Alzheimer's by 60% for patients in the earliest stages of the brain-wasting disease, according to trial data presented at a...
Gulf Today, Staff Reporter The UAE has become the world's second country that approves the registration and use of the Biogen's Aduhelm (aducanumab), the first and only drug for...
Max Nisen, Tribune News Service When the US Food and Drug Administration approved Biogen Inc.’s controversial Alzheimer’s drug Aduhelm earlier this month without firm evidence that the drug helps...
Leroy Hood, Tribune News Service My personal journey with Alzheimer’s began in 2005 when my wife, Valerie, received her diagnosis with this terrible disease, one that robs the afflicted...
Peter B. Bach and Craig Garthwaite, Tribune News Service The cost of caring for America’s nearly 6 million Alzheimer’s disease patients is already $600 billion a year, factoring in...
Gulf Today Report The American Alzheimer’s disease attacked Peter Marshall, fiercely, causing him to lose all his memories, but the man did not forget his love for his wife,...
Mariecar Jara-Puyod, Senior Reporter After three years of collaboration, a team of academician-scientists from the UAE, US and Sweden has designed and developed peptides believe to inhibit the progress...
Mariecar Jara-Puyod, Senior Reporter There is a new form of Alzheimer’s Disease (AD) identified as “Progressive Dysexecutive Syndrome (dAD), the onset of which is by age 40. dAD and...
